<DOC>
	<DOCNO>NCT01691456</DOCNO>
	<brief_summary>This open label , randomise , balance , two-treatment , two-period , two-sequence , single dose , crossover , oral bioequivalence study .</brief_summary>
	<brief_title>Bioequivalence Study Montelukast Sodium Oral Granules 4mg Under Fasting Condition</brief_title>
	<detailed_description>An open label , balance , randomize , two-treatment , two-period , two-sequence , single dose , crossover , oral bioequivalence study Montelukast Sodium Oral Granules 4mg Dr. Reddy 's Laboratories Limited , India compare SINGULAIRÂ® ( Montelukast sodium ) 4mg oral granule Merck Sharp &amp; Dohme Ltd. , USA healthy , adult , human subject fast condition .</detailed_description>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Subjects must fulfill follow criterion consider inclusion study . Healthy subject within age range 18 50 year . A body mass index 18.5 24.9 Kg/m2 Given write informed consent participate study . Absence disease marker HIV 1 &amp; 2 , hepatitis B &amp; C virus RPR . Absence significant disease clinically significant abnormal laboratory value laboratory evaluation , medical history physical examination screening . A normal 12lead ECG . A normal chest Xray ( PA view ) . Compliance requirement entire protocol . No history evidence hypersensitivity Montelukast component formulation . No history gastrointestinal problem ( ulcer ) . No history significant systemic disease . No history psychiatric disorder . No history allergic rash . No history addiction recreational drug drug dependence . No donation blood ( one unit 350 mL ) within 90 day prior study check . No Participation clinical study within past 90 day . No receipt prescription drug overthecounter drug ( e.g . : Cold preparation , antacid preparation vitamins natural product use therapeutic benefit ) , within two week prior study checkin . No history dehydration dialThea , vomit reason within period of24.0 hour prior study checkin . No family history neurological disorder . Not consume alcohol xanthine contain food beverage ( chocolate , tea , coffee cola drink : ) , cigarettes tobacco product , least 48.0 hour prior study checkin . Negative result drug abuse ( Benzodiazepines , Cocaines , Opioids , Amphetamines , Ca1U1abinoids Barbiturates ) urine day study checkin . Not consume grapefruit ( mosumbi/sweet lime ) juice within 48.0 hour prior study checkin . Negative alcohol breath analysis study checkin . Female volunteer demonstrate negative pregnancy test . If study volunteer female volunteer child bear potential practicing acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence . postmenopausal least 1 year . surgically . sterile ( bilateral tubal ligation , bilateral oophorectomy hysterectomy perform study volunteer ) . Exclusion Criteria The subject exclude base follow criterion . History seizure . Received pharmacological agent know significantly induce inhibit drug metabolize enzyme within 14 day start study . History alcohol consumption two units/day ( 1 unit = 30 mL spirit/or 1 pint beer ) , consume alcohol within 48 hour prior checkin . High caffeine ( 5 cup coffee tea/day ) tobacco ( 9 cigarettes/beedies/cigars per day ) consumption . History difficulty donate blood difficulty accessibility vein . An unusual abnormal diet , whatever reason e.g . fast due religious reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Montelukast Sodium</keyword>
	<keyword>crossover</keyword>
</DOC>